Could a daily bacterial pill stop infants from wheezing?
NCT ID NCT05064631
Summary
This study is testing if a daily capsule containing bacterial proteins can prevent wheezing in infants who were recently hospitalized for severe bronchiolitis. Researchers will give the capsule or a placebo to about 173 infants for up to two years to see if it reduces the number of wheezing episodes. The goal is to see if early exposure to these bacterial products can help prevent the development of persistent wheezing and asthma.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
King's College Hospital NHS Foundation Trust
London, SE5 9RS, United Kingdom
-
Royal London Hospital
London, E1 1FR, United Kingdom
-
University Hospital Southampton NHS Foundation Trust
Southampton, SO16 6YD, United Kingdom
Conditions
Explore the condition pages connected to this study.